pharmaceutical investing Iterum Initiates SURE 2 and SURE 3 Phase 3 Clinical Trials of IV and Oral Sulopenem in Complicated Urinary Tract and Complicated Intra-abdominal Infections
pharmaceutical investing Iterum Initiates SURE 1, a Phase 3 Clinical Trial of Oral Sulopenem in Uncomplicated Urinary Tract Infections
IBN Announces Latest Episode of The MiningNewsWire Podcast featuring Kimberly Ann, CEO of Lahontan Gold Corp.
Skyharbour's Partner Company UraEx Resources Commences Summer 2025 Drilling Program at South Dufferin Uranium Project, Athabasca Basin, Saskatchewan
Sranan Gold Announces Investor Webinar on Exploration Activities at the Tapanahony Project in Suriname